1. Home
  2. SCOR vs RFL Comparison

SCOR vs RFL Comparison

Compare SCOR & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$7.70

Market Cap

112.4M

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.57

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
RFL
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Real Estate
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
92.6M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
SCOR
RFL
Price
$7.70
$2.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
57.4K
230.3K
Earning Date
05-05-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
127.37
28.28
EPS
N/A
N/A
Revenue
$403,549,000.00
$917,000.00
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
43.96
52 Week Low
$4.81
$1.12
52 Week High
$10.18
$2.80

Technical Indicators

Market Signals
Indicator
SCOR
RFL
Relative Strength Index (RSI) 58.42 75.69
Support Level $6.27 $1.22
Resistance Level $8.55 N/A
Average True Range (ATR) 0.47 0.26
MACD -0.03 0.11
Stochastic Oscillator 48.20 79.33

Price Performance

Historical Comparison
SCOR
RFL

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: